Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Pharmaceuticals (Basel, Switzerland)|January 23, 2024
In Vitro Evaluation of Drug-Drug Interaction Potential of Epetraborole, a Novel Bacterial Leucyl-tRNA Synthetase InhibitorAfshin Shafiee, Sanjay Chanda
Environmental and Molecular Mutagenesis|April 30, 2013
An assessment of the genetic toxicology of novel boron-containing therapeutic agentsVic Ciaravino, Jacob Plattner, Sanjay Chanda
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|September 25, 2010
Inhibition and induction of human cytochrome P450 enzymes in vitro by capsaicinSunita Babbar, Sanjay Chanda, Keith Bley
Journal of Dermatological Science|April 19, 2017
2-Year animal carcinogenicity results for crisaborole, a novel phosphodiesterase 4 inhibitor for atopic dermatitisVic Ciaravino, Dina Coronado, Cheryl Lanphear, et al.
International Journal of Toxicology|May 24, 2006
Developmental toxicity study of pure trans-capsaicin in rats and rabbitsSanjay Chanda, Valerie Sharper, Alan Hoberman, et al.
Regulatory Toxicology and Pharmacology : RTP|July 30, 2005
Toxicity studies with pure trans-capsaicin delivered to dogs via intravenous administrationSanjay Chanda, Andrew Mould, Ashiq Esmail, et al.
Journal of Drugs in Dermatology : JDD|June 20, 2015
In Vitro Nail Penetration and Antifungal Activity of Tavaborole, a Boron-Based PharmaceuticalDina Coronado, Tejal Merchant, Sanjay Chanda, et al.
Dermatology Online Journal|May 3, 2016
Antifungal agents for onychomycosis: new treatment strategies to improve safetyLee T Zane, Sanjay Chanda, Dina Coronado, et al.
Pageof 3